Provided by Tiger Trade Technology Pte. Ltd.

Aurinia Pharmaceuticals

14.40
0.0000
Post-market: 14.400.00000.00%19:27 EST
Volume:549.76K
Turnover:7.90M
Market Cap:1.90B
PE:26.18
High:14.45
Open:14.39
Low:14.12
Close:14.40
52wk High:16.54
52wk Low:6.55
Shares:131.84M
Float Shares:128.06M
Volume Ratio:0.88
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5501
EPS(LYR):0.0400
ROE:20.65%
ROA:9.41%
PB:5.19
PE(LYR):360.00

Loading ...

BRIEF-Aurinia Pharmaceuticals To Report Financial Results For The Three And Twelve Months Ended December 31, 2025

Reuters
·
Feb 19

Aurinia Pharmaceuticals Inc. Updates Financial Calendar

Reuters
·
Feb 19

Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026

THOMSON REUTERS
·
Feb 19

Saturn Oil & Gas Completes Amalgamation with Subsidiaries

Reuters
·
Jan 02

STEP Energy Services Ltd. Held Shareholder Meeting

Reuters
·
Dec 13, 2025

Aurinia Pharmaceuticals Shares Fall After Leerink Partners Downgrade

MT Newswires Live
·
Dec 04, 2025

Aurinia Pharmaceuticals Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
Dec 03, 2025

Leerink Partners Downgrades Aurinia Pharmaceuticals to Market Perform From Outperform, Adjusts PT to $16 From $15

MT Newswires Live
·
Dec 03, 2025

Aurinia Pharmaceuticals Inc : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $16 From $15

THOMSON REUTERS
·
Dec 03, 2025

A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation Following Recent Share Price Gains

Simply Wall St.
·
Nov 28, 2025

Aurinia Pharmaceuticals Q3 Operating Income USD 29.745 Million

Reuters
·
Nov 20, 2025

Stock Track | Aurinia Pharmaceuticals Soars 5.04% Following Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Nov 12, 2025

Aurinia Pharmaceuticals (NasdaqGM:AUPH): Valuation Insights Following Strong Q3 Results and Raised 2025 Guidance

Simply Wall St.
·
Nov 11, 2025

Aurinia Pharmaceuticals Shares Rise After Jefferies Upgrade

MT Newswires Live
·
Nov 08, 2025

Stock Track | Aurinia Pharmaceuticals Soars 9.23% Pre-Market on Jefferies Upgrade and Doubled Price Target

Stock Track
·
Nov 07, 2025

Aurinia Pharmaceuticals Raised to Buy From Hold by Jefferies

Dow Jones
·
Nov 07, 2025

Aurinia Pharmaceuticals upgraded to Buy from Hold at Jefferies

TIPRANKS
·
Nov 07, 2025

Bloom Burton downgrades Aurinia Pharmaceuticals (AUPH) to a Hold

TIPRANKS
·
Nov 06, 2025

Stock Track | Aurinia Pharmaceuticals Plummets 5.05% Following RBC Downgrade to Sector Perform

Stock Track
·
Nov 05, 2025

Aurinia Pharmaceuticals Cut to Sector Perform From Outperform by RBC Capital

Dow Jones
·
Nov 05, 2025